Total Payments
$12,186
2024 Payments
$1,958
Companies
30
Transactions
740
Medicare Patients
8,711
Medicare Billing
$878,116
Payment Breakdown by Category
Food & Beverage$11,899 (97.6%)
Education$287.14 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,899 | 735 | 97.6% |
| Education | $287.14 | 5 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,638 | 151 | $0 (2024) |
| Janssen Biotech, Inc. | $1,431 | 131 | $0 (2024) |
| Amgen Inc. | $1,378 | 70 | $0 (2024) |
| Celgene Corporation | $1,374 | 93 | $0 (2019) |
| Lilly USA, LLC | $1,021 | 69 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $571.12 | 39 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $478.53 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $391.48 | 22 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $371.13 | 3 | $0 (2021) |
| GENZYME CORPORATION | $328.66 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,958 | 107 | Amgen Inc. ($356.17) |
| 2023 | $1,984 | 109 | E.R. Squibb & Sons, L.L.C. ($322.20) |
| 2022 | $1,383 | 94 | ABBVIE INC. ($256.38) |
| 2021 | $971.27 | 68 | AbbVie Inc. ($327.36) |
| 2020 | $600.68 | 32 | Amgen Inc. ($305.82) |
| 2019 | $1,432 | 95 | AbbVie, Inc. ($455.71) |
| 2018 | $1,665 | 104 | Celgene Corporation ($501.69) |
| 2017 | $2,191 | 131 | AbbVie, Inc. ($518.35) |
All Payment Transactions
740 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.99 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.96 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.08 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Immunology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.05 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Immunology | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Immunology | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.42 | General |
| 09/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,128 | 4,310 | $726,077 | $191,158 |
| 2022 | 30 | 2,141 | 4,099 | $705,341 | $210,073 |
| 2021 | 38 | 2,402 | 5,092 | $804,663 | $257,397 |
| 2020 | 30 | 2,040 | 5,370 | $729,312 | $219,488 |
Total Patients
8,711
Total Services
18,871
Medicare Billing
$878,116
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 445 | 853 | $176,855 | $48,050 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 528 | $138,235 | $43,144 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 322 | 421 | $107,172 | $28,071 | 26.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 251 | 442 | $62,150 | $12,191 | 19.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 78 | 120 | $36,150 | $10,210 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 153 | 153 | $37,820 | $9,478 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 98 | 132 | $22,810 | $4,683 | 20.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 93 | 93 | $17,335 | $3,710 | 21.4% |
| 11641 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 16 | 23 | $11,540 | $3,669 | 31.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 77 | 296 | $14,455 | $2,789 | 19.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $10,115 | $2,719 | 26.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 34 | $9,520 | $2,711 | 28.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 28 | 32 | $9,300 | $2,051 | 22.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 65 | 391 | $9,775 | $1,880 | 19.2% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 23 | 25 | $8,050 | $1,841 | 22.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 16 | $5,760 | $1,754 | 30.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $4,090 | $1,583 | 38.7% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $6,840 | $1,556 | 22.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 15 | $5,100 | $1,510 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,220 | $1,463 | 34.7% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $5,590 | $1,269 | 22.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $4,900 | $1,221 | 24.9% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $3,800 | $1,196 | 31.5% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $4,220 | $840.09 | 19.9% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 16 | 16 | $4,320 | $671.62 | 15.5% |
About Dr. Herschel Stoller, M.D
Dr. Herschel Stoller, M.D is a Dermatology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356324495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herschel Stoller, M.D has received a total of $12,186 in payments from pharmaceutical and medical device companies, with $1,958 received in 2024. These payments were reported across 740 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($11,899).
As a Medicare-enrolled provider, Stoller has provided services to 8,711 Medicare beneficiaries, totaling 18,871 services with total Medicare billing of $878,116. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology, Procedural Dermatology
- Location Omaha, NE
- Active Since 11/22/2005
- Last Updated 02/18/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356324495
Products in Payments
- Humira (Biological) $1,251
- Otezla (Drug) $1,069
- TALTZ (Drug) $1,021
- SKYRIZI (Biological) $797.81
- TREMFYA (Drug) $733.45
- DUPIXENT (Biological) $613.74
- Sotyktu (Drug) $571.12
- STELARA (Biological) $475.16
- RINVOQ (Biological) $330.97
- Enbrel (Biological) $314.61
- REMICADE (Biological) $300.90
- Tremfya (Drug) $292.33
- VTAMA (Drug) $286.25
- EUCRISA (Drug) $192.45
- OPZELURA (Drug) $172.30
- ILUMYA (Biological) $169.23
- Bimzelx (Biological) $162.78
- Skyrizi (Biological) $126.18
- ONEXTON (Drug) $124.99
- COSENTYX (Biological) $123.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Omaha
Joel Schlessinger, M.d, M.D
Dermatology — Payments: $307,419
Dermatology $307,419
Rachel Person, Aprn, APRN
Dermatology — Payments: $89,556
Dermatology $89,556
Dr. Mathew Davey, M.d, M.D
Dermatology — Payments: $34,777
Dermatology $34,777
Nicole Harter, M.d, M.D
Dermatology — Payments: $12,870
Dermatology $12,870
Dr. Jill Nelson, M.d, M.D
Dermatology — Payments: $11,785
Dermatology $11,785
Dr. Ronald Sulewski, M.d, M.D
Dermatology — Payments: $11,027
Dermatology $11,027